AuX Labs key facts
- Operator of a biotechnology company intended to develop alternative protein sources for food and human health.
- It has raised $3.1M; the latest was Early Stage VC in May 2025.
- Notable investors include Creative Destruction Lab, Congruent Ventures, Federal Economic Development Agency for Southern Ontario, IP2 Launchpad, Bluestein Ventures — 11 tracked in total.
- Status: Privately Held (backing).
Who backs AuX Labs
11+- ·The complete investor list: 11 names
- ·Watch AuX Labs: the Monday email on marks, rounds and moves
AuX Labs funding rounds
No funding rounds for AuX Labs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
AuX Labs investors
11 investors are on record for AuX Labs, including Creative Destruction Lab, Congruent Ventures, Federal Economic Development Agency for Southern Ontario and IP2 Launchpad.
About AuX Labs
Operator of a biotechnology company intended to develop alternative protein sources for food and human health. The company combines protein-yielding yeast strains with efficient bioprocesses that utilize low-cost feedstocks in capital-light fermentation facilities to produce nature-identical animal proteins, enabling consumers to avail of alternative proteins at a low price.
- Sector
- Healthcare
- HQ
- Toronto, Canada
- Founded
- 2021
- Employees
- 10
- Website
- auxlabs.ca/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
AuX Labs doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.